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1167-224 Short-Term Cardiac Memory: Phenotypically 
Heterogeneous Property of Myocardial Repolarization
Alexei Shvilkin, Seth McClennen, Panos Papageorgiou, Mathew Reynolds, Aneesh Tolat, 
Allison Richardson, Peter Zimetbaum, Mark E. Josephson, Beth Israel Deaconess 
Medical Center, Boston, MA
Background: Cardiac memory (CM) represents persistent T wave changes after a
period of aberrant ventricular activation (ventricular pacing, ventricular arrhythmias) upon
resumption of normal conduction that are associated with changes in ion channel func-
tion, refractoriness and response to antiarrhythmic drugs in animal models. Clinical sig-
nificance of CM in humans is largely unknown. We hypothesized that a wide variation
exists in CM expression in humans that reflects heterogeneity of individual repolarization
properties and therefore might convey clinically relevant information.
Methods: Short-term CM was induced in eighteen patients (M/F 13/5, age 28-88 years)
referred for electrophysiological study. Four minutes of atrial pacing (AP) at a cycle length
(CL) of 600- 800 ms established the baseline (BL) with stable QT. CM was induced by
right ventricular AV sequential pacing (A-RVP) with short AV delay at the same CL for 15
min. A-RVP was interrupted by 10 s of AP at 1, 5, 10, and 15 min to observe CM. Vector-
cardiograms were reconstructed from digitally acquired 12-lead ECG using inverse Dover
transform. CM was quantified by 3-dimensional displacement of T vector peak (TPd) in
orthogonal leads and QT change.
Results: CM magnitude increased over the course of A-RVP with TPd = 50 ± 9; 82 ± 10;
105 ± 16; 101 ± 15 µV after 1, 5, 10, and 15 min of A-RVP, resp, p<0.01. Maximal individ-
ual CM magnitude varied from 20 to 229 µV. AP QT shortened from 371 ± 5 ms at BL to
360 ± 4 ms after 15 min of A-RVP (p<0.05). A-RVP QT shortened from 404 ± 9 ms at
onset to 392 ± 9 ms at 15 min of A-RVP (p<0.01). TPd did not correlate with clinical vari-
ables (age, sex, EF, medications) or QT shortening.
Conclusion: A period of altered ventricular activation sequence modifies repolarization
resulting in CM and QT shortening during both AP and A-RVP at a constant CL. There is
marked heterogeneity of short-term CM in terms of both T vector and QT interval
changes. Considerable differences exist in myocardial ability to conform to a new activa-
tion sequence in humans. Prospective clinical outcome studies will define clinical signifi-
cance of these findings.
1167-225 Lead Position and Long-Term Survival With 
Biventricular Pacing
Dusan Z. Kocovic, Heather M. Ross, Douglas Laidlaw, Thomas Lynn, Main Line Heart 
Center, Wynnewood, PA
Background: Cardiac resynchronization therapy (CRT) has been shown to improve
NYHA functional class, exercise capacity, quality of life (QOL), and survival in patients
with moderate to severe heart failure and wide QRS complex. The optimal site for left
ventricular (LV) pacing was established in acute hemodynamic studies, but long-term
impact of different LV stimulation sites is unknown.
Methods: We examined the impact of LV lead position on mortality of 106 consecutively
implanted CRT patients with long-term follow-up (18-46 months). At baseline, ejection
fraction (EF) was <35%, QRS >130 msec, NYHA class III (n=90) or IV (n=16). Patients
were followed clinically at 6 month intervals with echo, 6 minute walk test, and QOL ques-
tionnaire. 30 patients had the LV lead implanted in an anterior or septal position (group
1), and 76 in a lateral, posterolateral, or anterolateral position (group 2) on the LV wall.
Results: At 12 months follow-up, patients with lateral position (group 2) improved more
than patients with anterior or septal lead position (group 1) in 6 minute walk test (p<0.05),
functional class (p<0.001), QOL (p<0.05), and EF (p<0.05). 90 percent of patients in
group 2 were alive versus 75 percent of patients in group 1 (p<0.05 log rank test). Fewer
patients in group 2 required hospitalization or intravenous medications for the treatment
of HF, compared to group 1.
Conclusion: CRT with LV lead position in the left lateral wall results in more significant
clinical improvement and better survival than with LV lead position in a septal or anterior
position.
1167-226 Outcome of Resynchronization Therapy in Patients With 
Atrial Fibrillation
Barbara Lamp, Juergen Vogt, Lothar Faber, Johannes Heintze, Bert Hansky, Uwe 
Schulz, Reiner Koerfer, Dieter Horstkotte, Heart Center North Rhine-Westphalia, Bad 
Oeynhausen, Germany
Resynchronisation therapy (RT) in patients (p) with severe heart failure (CHF) and left
bundle branch block (LBBB) is successful. However conflicting data exist for p with atrial
fibrillation (AF).
In this study we analysed 313 p (mean age 62±10 years (y), 174 DCM, 110 CAD, 29
other, mean FU 18.2 ± 12.4 m) who received RT with respect to the underlying rhythm at
baseline. Baseline characteristics in the two groups show no statistical differences
between SR-pts. and the AF-pts. (26 x permanent AF, 17 x intermittent AF, 6xAF and
VVI-PM) concerning age, oxygen consumption at anaerobic threshold (VO2AT), work-
load, 6 min. walking distance, LVEDD, LVEF and QRS-width. NYHA class and peak oxy-
gen consumption (VO2peak) are better in the SR-group (p<0.05, unpaired t-test). The
proportion of pts. with valvular disease is larger in AF than in SR (16% versus 8% in SR).
After 3, 6 and 12 m, the clinical course in the AF group seems less beneficial (table) with
22.5 % pump failure as opposed to 13.2% in SR.
Our data show a favourable outcome after RT for pts. with normal SR. However in pts.
with preexisting AF the clinical benefit seems to be less sustained. These results are
comparable to those of the AF-arm in MUSTIC. 
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860-1 The Success of Surgical Pulmonary Vein Isolation for 
Atrial Fibrillation Is Not Influenced by Omission of the 
Mitral Annular Connecting Lesion
Deon W. Vigilance, Brian Kim, Mauricio Garrido, Mathew Williams, Joy Peacock, Ann 
Zeidner, Aftab R. Kherani, Jeffery A. Morgan, Satish Kesava, Mehmet C. Oz, Michael 
Argenziano, Columbia University, New York, NY
Background: Surgical atrial fibrillation ablation (SAFA) has emerged as an alternative to
the Maze procedure. Although several left atrial lesion patterns have been utilized, most
have included pulmonary vein isolation (PVI) and a "connecting lesion" to the mitral
annulus. Since this connecting lesion is difficult to create epicardially, we evaluated
whether its omission would have an impact on success of SAFA.
Methods: Over 42 months, 210 patients underwent SAFA for AF as a lone or concomi-
tant cardiac procedure. Early in our experience, all procedures included PVI and a con-
necting mitral valve lesion (Group I, n=118). More recently, we have performed only PVI
(Group II, n=69). Postoperative electrocardiograms were monitored at regular intervals.
Success was defined as freedom from AF or atrial flutter (AFL).
Results: There were 23 deaths in the follow-up period. In the remaining 187 patients,
mean age was 65.6+12.3 years and mean duration of preoperative AF was 7.5+10.1 yrs.
At a mean follow-up of 10.6+10.5 months, patients in Groups I and II had success rates
of 69.5% (82/118) and 65.2% (45/69), respectively (p=0.627). Groups I and II also had
similar rates of postoperative AFL (8.5% vs. 8.7%, respectively [p=0.809]).
Conclusions: In patients undergoing surgical atrial fibrillation ablation, the connecting
lesion to the mitral annulus neither influences the success of the procedure nor alters the
incidence of postoperative atrial flutter. These findings suggest that an epicardial ablative
procedure consisting only of pulmonary vein isolation is a reasonable option in the treat-
ment of atrial fibrillation.
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860-2 Morphology of Intraoperative Radiofrequency Ablation 
to Treat Atrial Fibrillation
Thomas Deneke, Krishna Khargi, Peter H. Grewe, Axel Laczkovics, Bernd Lemke, Klaus-
Michael Müller, Medical Clinic II, Bochum, Germany, Institute of Pathology, Bochum, 
Germany
Intraoperative cooled-tip radiofrequency ablation (SICTRA) is an effective treatment of
chronic atrial fibrillation (AF). Ablation lines in the atria aim at producing electric conduc-
tion block. Morphological effects in human atrial tissue have not been systematically ana-
lyzed.
Methods: 8 patients died 2 to 64 days after open heart surgery plus additional SICTRA to
treat chronic permanent af (duration 5±4 years). The atria were analyzed in topographic
correlation to the ablation pattern by macroscopy, microscopy and immunohistochemis-
try.
Table 1
parameter baseline (n=20) 6 months (n=14)
NYHA 3.1±0.4 2.4±0.6*
VO2peak (ml/kg/min) 13.6±2.1 14.1±3.1
VO2AT (ml/kg/min) 10.6±2.2 12.0±4.4
6-min walk (m) 310.0±118.7 385.5±120.7
QOL 75.2±10.6 25.6±22.7
LVEDD (mm) 75.2±10.6 67.0±10.6*
